Moreover, recent evidence [17] has indicated that reduced expression of DEFB1 is found in a high percentage of renal and prostate cancers, therefore suggesting that DEFB1 acts as a tumor suppressor gene. The gene discussed is DEFB1; the disease is prostate carcinoma.